A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Ocellaris Pharma, Inc.
Ocellaris Pharma, Inc.
Actym Therapeutics, Inc.
Pfizer
NuCana plc
University of Virginia
Seagen Inc.
Sotio Biotech Inc.
Aminex Therapeutics, Inc.
Inhibrx Biosciences, Inc
ADC Therapeutics S.A.
University of Florida
Fate Therapeutics
Incyte Corporation
Seagen Inc.
KitovPharma
CureOne
MedInnovation GmbH
New Mexico Cancer Research Alliance